TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03593473 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04557059 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT04557059 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04941742 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02624921 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02496221 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT05015543 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05015543 — Safety Biomarker (SAF): BDNF
Study NCT04618952 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04455594 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04368325 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01661582 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03602833 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT03986372 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03986372 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT00412529 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01492673 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01492673 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02706639 — Predictive Biomarker (PRD): ELN mRNA
Genes: ELN
Study NCT04395950 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04395950 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00553358 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03845322 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03459833 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04222465 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01127386 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02483767 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02483767 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02483767 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00165711 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02454634 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT02525302 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00237328 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study NCT01299415 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT00300430 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00131807 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03205202 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03495492 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02325843 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03044392 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05895916 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05895916 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02530047 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01162395 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT01162395 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02595645 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02509559 — Predictive Biomarker (PRD): ADRB1 mRNA
Genes: ADRB1; ADRB1R; B1AR
Study NCT02509559 — Predictive Biomarker (PRD): ADRB2 mRNA
Genes: ADRB2; ADRB2R; B2AR
Study NCT03919812 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT03919812 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT00973037 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03341117 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT00231907 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT03393832 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02856815 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00908739 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02787486 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03752840 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03228368 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02537652 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01800188 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02357511 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01573312 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04659902 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01288339 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01288339 — Predictive Biomarker (PRD): MMP7 mRNA
Genes: MMP7; MPSL1; PUMP1
Study NCT01623232 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study NCT03837184 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT02983604 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02983604 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00858078 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00858078 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT02785809 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02855632 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00533754 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03507530 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05757232 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01856023 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00841308 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02867891 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01787097 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT01787097 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03067298 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT03067298 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT03067298 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02232880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03874260 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03505710 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02314273 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT01923025 — Predictive Biomarker (PRD): PDE10A mRNA
Genes: PDE10A
Study NCT00004904 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04523662 — Predictive Biomarker (PRD): CXCL16 mRNA
Genes: CXCL16; SCYB16; SRPSOX; UNQ2759/PRO6714
Study NCT00125125 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00125125 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02634983 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01081496 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04072731 — Predictive Biomarker (PRD): SREBF1 mRNA
Genes: SREBF1; BHLHD1; SREBP1
Study NCT00929240 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01999231 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00438958 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03387111 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00005993 — Predictive Biomarker (PRD): KITLG mRNA
Genes: KITLG; MGF; SCF
Study NCT00005993 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01801371 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00058461 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03802214 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04524078 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03650946 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01511055 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT03885921 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT03885921 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01443013 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT01027273 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01415388 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02290210 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00603486 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00308724 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT02310373 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00095563 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01661322 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02819778 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT00606879 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00492466 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03501979 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01517035 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01517035 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04269382 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01298596 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02228967 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT05060809 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT01917877 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01917877 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01917877 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02083653 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02083653 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03089099 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01599455 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00591188 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03171389 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01369329 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00340301 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT03206788 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04013022 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04716556 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04360278 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02156245 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02828137 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT00995332 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT03088514 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01294228 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02755233 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00519870 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00519870 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT00999271 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00999271 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00806013 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00806013 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00688337 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT01319331 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT04081259 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study NCT05751525 — Predictive Biomarker (PRD): KCNJ11 mRNA
Genes: KCNJ11
Study NCT03844295 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00384111 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01947023 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01947023 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00675870 — Predictive Biomarker (PRD): NXN mRNA
Genes: NXN; NRX
Study NCT00139490 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00420290 — Safety Biomarker (SAF): Interleukin 1
Study NCT02762877 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02762877 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02762877 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study NCT02044276 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study NCT01224548 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01480271 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT01480271 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02012582 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00895297 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00895297 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00384358 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT00667719 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02153931 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03446144 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00770146 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03582501 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00518960 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04503733 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03145181 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT03990129 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT03990129 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03990129 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03990129 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03990129 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03990129 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02778568 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02051075 — Predictive Biomarker (PRD): PXN mRNA
Genes: PXN
Study NCT00595907 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02708784 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT01623258 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT04924127 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT00370214 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02338843 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT01848379 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02647151 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT00425178 — Safety Biomarker (SAF): Fibroblast growth factor 1
Genes: FGF1
Study NCT02557074 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00123890 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01421095 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03945279 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02162511 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02293811 — Predictive Biomarker (PRD): P2RX7 mRNA
Genes: P2RX7
Study NCT02916121 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02071940 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT04352491 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01874678 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01335971 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT05143710 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01535157 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT04345731 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT01935895 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02905396 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT00233909 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT00005172 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00021983 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01485224 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01485224 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03008772 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT06645340 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00472693 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02567136 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT01705626 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT01705626 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT00896389 — Predictive Biomarker (PRD): STK39 mRNA
Genes: STK39; SPAK
Study NCT01510314 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01510314 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01453387 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study NCT01256970 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT04528485 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00055640 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT02717156 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04405934 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02202330 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03413176 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03413176 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04397432 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03504943 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03093584 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02246712 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00716950 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04545944 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01426789 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study NCT01494389 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02203201 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT02203201 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT02612480 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02612480 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02612480 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT02789384 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT00168259 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00168259 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00499109 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study NCT00499109 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT01152606 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04376619 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04501861 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT04501861 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT03767725 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT02438358 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study NCT01335802 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT02390219 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02248558 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04234724 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study NCT00699192 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00837187 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00891735 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02276027 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02276027 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02276027 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK